Mehta Kishan has filed 8 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 68693 shares of Biohaven Ltd. ($BHVN) on April 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 28, 2026 | Biohaven Ltd. | $BHVN | Mehta Kishan | Director | A | Stock Options (Right to buy) | 68693 | $0.00 | 68,693.0000 | 105,855,155 | 9999.99% | 0.06% |
| March 17, 2026 | Biohaven Ltd. | $BHVN | Mehta Kishan | Director | G | Common Shares | 17342 | $0.00 | 22,662.0000 | 105,855,155 | 43.35% | 0.02% |
| March 17, 2026 | Biohaven Ltd. | $BHVN | Mehta Kishan | Director | G | Common Shares | 17342 | $0.00 | 22,662.0000 | 105,855,155 | 325.98% | 0.02% |
| Dec. 1, 2025 | Benitec Biopharma Inc. | $BNTC | Mehta Kishan | Director | A | Options (right to buy) | 35000 | $0.00 | 35,000.0000 | 37,254,839 | 9999.99% | 0.09% |
| May 5, 2025 | Biohaven Ltd. | $BHVN | Mehta Kishan | Director | A | Stock Options (Right to buy) | 31716 | $0.00 | 31,716.0000 | 102,054,499 | 9999.99% | 0.03% |
| Dec. 9, 2024 | Benitec Biopharma Inc. | $BNTC | Mehta Kishan | Director | A | Options (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| April 30, 2024 | Biohaven Ltd. | $BHVN | Mehta Kishan | Not found | A | Stock Option (Right to Buy) | 16592 | $0.00 | 16,592.0000 | 0 | 9999.99% | 0.00% |
| May 2, 2023 | Biohaven Ltd. | $BHVN | Mehta Kishan | Not found | A | Stock Option (Right to Buy) | 52906 | $0.00 | 52,906.0000 | 0 | 9999.99% | 0.00% |